Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis

References

• Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009;360:1989–2003.
   Google Scholar
• Gruschwitz MS, Hornstein OP, von Den DP. Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity. Arthritis Rheum 1995;38:184–9.
   Google Scholar
• Kahaleh B. Vascular disease in scleroderma: mechanisms of vascular injury. Rheum Dis Clin North Am 2008;34:57–71.
   Google Scholar
• Koch AE, Distler O. Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis. Arthritis Res Ther 2007;9(Suppl 2):S3.
   Web of Science ®Google Scholar
• VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003;59:277–87.
   PubMed Web of Science ®Google Scholar
• Morel O, Morel N, Freyssinet JM, Toti F. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses. Platelets 2008;19:9–23.
   PubMed Web of Science ®Google Scholar
• Connor DE, Exner T, Ma DD, Joseph JE. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb Haemost 2010;103:1044–52.
   PubMed Web of Science ®Google Scholar
• Distler JH, Huber LC, Gay S, Distler O, Pisetsky DS. Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity 2006;39:683–90.
   PubMed Web of Science ®Google Scholar
• Horstman LL, Jy W, Jimenez JJ, Ahn YS. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004;9:1118–35.
   PubMed Web of Science ®Google Scholar
• Perez-Pujol S, Marker PH, Key NS. Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer. Cytometry A 2007;71:38–45.
   PubMed Web of Science ®Google Scholar
• Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, Ahn YS. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 2003;109:175–80.
   PubMed Web of Science ®Google Scholar
• Leroyer AS, Anfosso F, Lacroix R, Sabatier F, Simoncini S, Njock SM, et al. Endothelial-derived microparticles: biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis. Thromb Haemost 2010;104:456–63.
   Google Scholar
• Gyorgy B, Szabo TG, Pasztoi M, Pal Z, Misjak P, Aradi B, et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 2011;68:2667–88.
   PubMed Web of Science ®Google Scholar
• Heloire F, Weill B, Weber S, Batteux F. Aggregates of endothelial microparticles and platelets circulate in peripheral blood. Variations during stable coronary disease and acute myocardial infarction. Thromb Res 2003;110:173–80.
   Google Scholar
• Joop K, Berckmans RJ, Nieuwland R, Berkhout J, Romijn FP, Hack CE, et al. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost 2001;85: 810–20.
   PubMed Web of Science ®Google Scholar
• Nielsen CT, Ostergaard O, Johnsen C, Jacobsen S, Heegaard NH. Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. Arthritis Rheum 2011;63:3067–77.
   PubMed Web of Science ®Google Scholar
• Alon R, Ley K. Cells on the run: shear-regulated integrin activation in leukocyte rolling and arrest on endothelial cells. Curr Opin Cell Biol 2008;20:525–32.
   PubMed Web of Science ®Google Scholar
• Tabuchi A, Kuebler WM. Endothelium-platelet interactions in inflammatory lung disease. Vascul Pharmacol 2008;49:141–50.
   Google Scholar
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581–90.
   Google Scholar
• LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA. Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15: 202–5.
   PubMed Web of Science ®Google Scholar
• Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281–5.
   PubMed Web of Science ®Google Scholar
• Iversen LV, Ostergaard O, Nielsen CT, Jacobsen S, Heegaard NH. A heparin-based method for flow cytometric analysis of microparticles direct from platelet-poor plasma in calcium containing buffer. J Immunol Methods 2013;388:49–59.
   Google Scholar
• Guiducci S, Distler JH, Jungel A, Huscher D, Huber LC, Michel BA, et al. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis Rheum 2008;58:2845–53.
   PubMed Web of Science ®Google Scholar
• Nomura S, Inami N, Ozaki Y, Kagawa H, Fukuhara S. Significance of microparticles in progressive systemic sclerosis with interstitial pneumonia. Platelets 2008;19:192–8.
   PubMed Web of Science ®Google Scholar
• Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010;107:1047–57.
   PubMed Web of Science ®Google Scholar
• Sapet C, Simoncini S, Loriod B, Puthier D, Sampol J, Nguyen C, et al. Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. Blood 2006;108:1868–76.
   PubMed Web of Science ®Google Scholar
• Cerinic MM, Valentini G, Sorano GG, D’Angelo S, Cuomo G, Fenu L, et al. Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis. Semin Arthritis Rheum 2003;32:285–95.
   PubMed Web of Science ®Google Scholar
• Hernandez-Rodriguez NA, Cambrey AD, Harrison NK, Chambers RC, Gray AJ, Southcott AM, et al. Role of thrombin in pulmonary fibrosis. Lancet 1995;346:1071–3.
   PubMed Web of Science ®Google Scholar
• Eichhorn ME, Ney L, Massberg S, Goetz AE. Platelet kinetics in the pulmonary microcirculation in vivo assessed by intravital microscopy. J Vasc Res 2002;39:330–9.
   PubMedGoogle Scholar
• McVey MJ, Tabuchi A, Kuebler WM. Microparticles and acute lung injury. Am J Physiol Lung Cell Mol Physiol 2012;303:L364–81.
   PubMed Web of Science ®Google Scholar
• van der Zee PM, Biro E, Ko Y, de Winter RJ, Hack CE, Sturk A, et al. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem 2006;52:657–64.
   PubMed Web of Science ®Google Scholar
• Andre P. P-selectin in haemostasis. Br J Haematol 2004;126: 298–306.
   PubMed Web of Science ®Google Scholar
• Chironi GN, Boulanger CM, Simon A, Dignat-George F, Freyssinet JM, Tedgui A. Endothelial microparticles in diseases. Cell Tissue Res 2009;335:143–51.
   PubMed Web of Science ®Google Scholar
• Blann AD, Constans J, Carpentier P, Renard M, Satger B, Guerin V, et al. Soluble P selectin in systemic sclerosis: relationship with von Willebrand factor, autoantibodies and diffuse or localised/limited disease. Thromb Res 2003;109:203–6.
   PubMedGoogle Scholar
• Kumanovics G, Minier T, Radics J, Palinkas L, Berki T, Czirjak L. Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis. Clin Exp Rheumatol 2008;26:414–20.
   PubMed Web of Science ®Google Scholar
• Kuryliszyn-Moskal A, Klimiuk PA, Sierakowski S. Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement. Clin Rheumatol 2005;24:111–16.
   PubMed Web of Science ®Google Scholar
• Olewicz-Gawlik A, Danczak-Pazdrowska A, Klama K, Silny W, Prokop J, Mackiewicz S, et al. Blood serum levels of amino-terminal pro-C-type natriuretic peptide in patients with systemic sclerosis. Connect Tissue Res 2010;51:83–7.
   PubMed Web of Science ®Google Scholar
• Sfikakis PP, Charalambopoulos D, Vaiopoulos G, Mavrikakis M. Circulating P- and L-selectin and T-lymphocyte activation and patients with autoimmune rheumatic diseases. Clin Rheumatol 1999;18:28–32.
   PubMedGoogle Scholar
• Stratton RJ, Coghlan JG, Pearson JD, Burns A, Sweny P, Abraham DJ, et al. Different patterns of endothelial cell activation in renal and pulmonary vascular disease in scleroderma. Q J Med 1998;91:561–6.
   Google Scholar
• Ara J, Mirapeix E, Arrizabalaga P, Rodriguez R, Ascaso C, Abellana R, et al. Circulating soluble adhesion molecules in ANCA-associated vasculitis. Nephrol Dial Transplant 2001;16: 276–85.
   PubMed Web of Science ®Google Scholar
• Peterson DB, Sander T, Kaul S, Wakim BT, Halligan B, Twigger S, et al. Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles. Proteomics 2008;8:2430–46.
   PubMed Web of Science ®Google Scholar
• Katsumoto TR, Whitfield ML, Connolly MK. The pathogenesis of systemic sclerosis. Annu Rev Pathol 2011;6:509–37.
   PubMed Web of Science ®Google Scholar
• Mesri M, Altieri DC. Endothelial cell activation by leukocyte microparticles. J Immunol 1998;161:4382–7.
   PubMed Web of Science ®Google Scholar